Loading...
NPI 1831850627 · Chicago, IL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Unic Labs LLC is a clinical medical laboratory provider located in Chicago, Illinois. This profile covers 1 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Unic Labs LLC |
| Address | 4202 N Milwaukee Ave |
| City | Chicago |
| State | IL |
| ZIP | 60641 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | January 4, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $6.7M |
| Medicaid | $0 |
UNIC LABS LLC’s Medicare billing is almost entirely concentrated in one service line: the listed top code is K1034 (Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count), which accounts for $6.7M in Medicare revenue. The code mix and description point to a business model focused on provision/distribution of over-the-counter or at-home COVID-19 test kits rather than a broad suite of clinical laboratory diagnostics.
Revenue concentration is extreme: the precomputed top-3 Medicare codes account for 100.0% of this provider’s total Medicare revenue, indicating the provider’s Medicare footprint is highly concentrated into a very small set of billable services. This level of concentration implies that changes to reimbursement, coding guidance, or demand for that specific service would materially affect the provider’s Medicare revenue profile.
Scale and payment profile show high volume but low per-claim payment: UNIC LABS reported 555.3K claims for K1034 with an average paid/claim of $12, producing $6.7M in Medicare revenue. This claim volume alongside a modest average payment is consistent with mass distribution of low-cost, single-test items rather than high-value clinical procedures.
Payer mix is effectively single-payer: the provider reports $6.7M in Medicare revenue and $0 in Medicaid revenue, which indicates either no Medicaid billing for the services captured here or negligible Medicaid participation for these codes. Analysts should treat UNIC LABS as operating largely within the Medicare reimbursement channel for the period covered.
Competitive standing for K1034 is nationally prominent: UNIC LABS ranks #74 of 30143 providers nationally for this code and is described as an "extreme outlier, far above typical national volume for this code." This rank and percentile positioning signal the provider is a major national-volume participant for at-home/nonprescription COVID test provisioning.
Tenure is short relative to the scale achieved: the NPI was enumerated on 2022-01-04 (~4 years ago), so the organization reached substantial Medicare billing volumes for K1034 within a few years of enumeration. That rapid scale-up is notable for analysts tracking entrant behavior in pandemic-related testing markets.
The absence of other common clinical laboratory CPTs among the top-billed items and the lack of Medicaid revenue suggest UNIC LABS does not report meaningful traditional lab testing activity to Medicare or Medicaid in this dataset. This pattern reinforces the interpretation that the entity’s operations are narrowly focused on the specific at-home COVID-19 test code rather than a diversified clinical lab service mix.
From a market-risk and strategic perspective, the provider’s reliance on a single high-volume code (K1034) makes its Medicare revenue profile sensitive to shifts in public-health testing demand and policy or payer changes affecting at-home COVID test reimbursement. For competitive benchmarking, UNIC LABS should be viewed as a specialized, high-volume provider for this single service rather than a conventional clinical medical laboratory with broad service lines.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 555,290 | $10 | $6.7M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 24 | 1,150 | 720 | $10 | $414.9K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 690 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 28 | 60 | 660 | $1 | $3.2K |
Other providers in the same ZIP code as Unic Labs LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.